title: Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters.
abstract: Homocystinuria is a rare inherited metabolic disease. Arterial and venous thromboembolic events represent frequent and life-threatening complications in homocystinuric patients. It has been suggested that mild homocysteinemia could be a risk factor for vascular disease. We have therefore measured total plasma homocysteine (HCy) concentrations by radioisotopic assay in 50 subjects with venous or arterial thrombosis and studied the relationship between HCy, coagulation and fibrinolytic parameters. Values were considered abnormal if they were higher than 2.7 standard deviations (SD) above the mean, i.e., 14.1 mmol/l. Thus, eighteen of the 50 patients with thrombosis were classified in the hyperhomocysteinemia group. Nine of these subjects had only this isolated risk factor. No correlations were found between HCy and antithrombin III, protein C, protein S and plasminogen levels, or plasma plasminogen activator inhibitor activity. Nevertheless, the correlation between tissue-plasminogen activator antigen and total plasma HCy was significant (r = 0.61, p < 0.001). Increased homocysteinemia seems to be a risk factor for thrombotic events especially knowing that HCy presents a direct cytotoxic effect. Vitamin therapy, already used in homozygote homocystinuric patients, might be beneficial in the prevention of thromboembolic disease in heterozygous patients.
authors.affiliation: Laboratoire de Biochimie Génétique, Hôpital Necker Enfants Malades, Paris, France.
authors.forename: T
authors.initials: T
authors.lastname: Bienvenu
authors.forename: A
authors.initials: A
authors.lastname: Ankri
authors.forename: B
authors.initials: B
authors.lastname: Chadefaux
authors.forename: G
authors.initials: G
authors.lastname: Montalescot
authors.forename: P
authors.initials: P
authors.lastname: Kamoun
mesh_terms: D000293:Adolescent; D000328:Adult; D001327:Autoimmune Diseases / Q000150:complications; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000150:complications; D001798:Blood Proteins / Q000032:analysis; D005260:Female; D005342:Fibrinolysis; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000150:complications; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood* / Q000453:epidemiology / Q000209:etiology
chemical_list: D001798:Blood Proteins; D006710:Homocysteine